Company / CapEx per Share
ANI Pharmaceuticals, Inc. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.66
FY2025
5-year range
$0.20 / $1.00
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
#19 of 192
Health Care
What the data says
Among 192 Health Care companies, ANI Pharmaceuticals, Inc. is in the top 10% for capex per share. CapEx per Share has fluctuated over the past 10 years, ranging from $0.20 in FY2021 to $1.00 in FY2024.
Based on SEC 10-K filings.
0.66 in FY2025 with a 5-year CAGR of +5.0%. Top quartile in the Health Care sector.
Improved from $0.49 to $0.66 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +6.3%
- 5-Year CAGR
- +5.0%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 192This company $0.66 Sector average $3.54
▼
-81.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 34.4% year-over-year.
- Ranks #19 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | -34.4% |
| FY2024 | $1.00 | +104.9% |
| FY2023 | $0.49 | -10.7% |
| FY2022 | $0.55 | +168.9% |
| FY2021 | $0.20 | -60.4% |
| FY2020 | $0.51 | -10.8% |
| FY2019 | $0.57 | +17.8% |
| FY2018 | $0.49 | -45.6% |
| FY2017 | $0.90 | +127.4% |
| FY2016 | $0.39 | -99.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026